Shanghai Haoyuan Chemexpress Co., Ltd.

Shanghai Stock Exchange 688131.SS

Shanghai Haoyuan Chemexpress Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2023: USD 68.12 M

Shanghai Haoyuan Chemexpress Co., Ltd. Cash and Short-Term Investments is USD 68.12 M for the year ending December 31, 2023, a -1.53% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

Shanghai Haoyuan Chemexpress Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2022 was USD 69.17 M, a -57.62% change year over year.
Shanghai Haoyuan Chemexpress Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2021 was USD 163.23 M, a 264.86% change year over year.
Shanghai Haoyuan Chemexpress Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2020 was USD 44.74 M, a 53.60% change year over year.
Shanghai Haoyuan Chemexpress Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2019 was USD 29.13 M, a 150.42% change year over year.

Key data

Date	Cash and Short-Term Investments	Receivables	Inventory	Goodwill

Shanghai Stock Exchange: 688131.SS

Shanghai Haoyuan Chemexpress Co., Ltd.

CEO	Mr. Baofu Zheng
IPO Date	June 8, 2021
Location	China
Headquarters	No. 3 Building, No. 1999
Employees	3,370
Sector	Health Care
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials

Description

Shanghai Haoyuan Chemexpress Co., Ltd. researches and develops pharmaceutical intermediates and small molecule drugs. It manufactures APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.

Key trends

Past 5 years